Abstract: A needle-less device for the parenteral administration of a medicament is disclosed. The medicament has the shape of one end of a toothpick. It is placed in the bore of a barrel with the barrel having the shape of a nose cone at one end. A plunger is inserted into the other end of the bore. The plunger forces the medicament through the skin and into subcutaneous layer of the patient without the need for the penetration of the skin by a needle.
Abstract: A sustained release drug formulation including: a drug; a biodegradable polymer which is insoluble in water; and an oil vehicle in which both the drug and the polymer are dissolved. The oil vehicle contains 10-100% by volume a pharmaceutically acceptable oil and 0-90% by volume a pharmaceutically acceptable liquid carrier for the drug or the polymer.
Type:
Grant
Filed:
January 16, 1996
Date of Patent:
November 9, 1999
Assignee:
Societe de Conseils de Recherches et d'Applications Scientifique S.A.
Abstract: The invention relates to pharmaceutical compositions for neuroprotection containing the compound (1S,2R) 1-[1-(2-thienyl)-2-alkylcyclohexyl]piperidine or (1S,2R) 1-[1-(2-furanyl)-2-alkylcyclohexyl]piperdine, or their pharmaceutically acceptable salts. The synthesis and method separation of racemic mixtures to provide pure enantiomers is presented. The compositions have use in the treatment of stroke, CNS trauma and Alzheimer's disease.
Type:
Grant
Filed:
December 10, 1996
Date of Patent:
October 26, 1999
Assignee:
Le Centre National De La Recherche Scientifique
Abstract: Peptide variants of fragment of parathyroid hormone (PTH) or parathyroid hormone-related protein (PTHrP), in which at least one of the amino acid residues is replaced with Acc.
Type:
Grant
Filed:
March 7, 1997
Date of Patent:
September 21, 1999
Assignee:
Societe De Conseils De Recherches Et D'Applications Scientifiques, S.A.
Abstract: A cyclodextrin derivative, wherein at least 60 percent of the free hydroxy groups of said cyclodextrin are acylated with acyl groups where at least one of said acyl groups comprise a free carboxylic group.
Type:
Grant
Filed:
November 1, 1996
Date of Patent:
June 29, 1999
Assignee:
Poly-Med, Inc.
Inventors:
Shalaby W. Shalaby, Joel Thomas Corbett
Abstract: A transgenic mouse containing an IGF-1 transgene which is operably linked to a promoter sequence and is expressed in the pancreas of the mouse.
Abstract: A copolymer comprising an N-acylated derivative, and a composition comprising said copolymer and a polypeptide, said polypeptide comprising at least one effective ionogenic amine, wherein at least 50 percent, by weight, of said polypeptide present in said composition is ionically bound to said polymer.
Type:
Grant
Filed:
September 9, 1997
Date of Patent:
October 13, 1998
Assignee:
Biomeasure, Incorporated
Inventors:
Shalaby W. Shalaby, Steven A. Jackson, Francis Ignatious, Jacques-Pierre Moreau